Altima Partners LLP is a private equity general partner firm headquartered in London, United Kingdom.
Histogenics, a VC-backed regenerative medicine developer, has debuted its IPO after pricing its 5.9m shares for a total of about $65m.
Sofinnova Ventures, Split Rock and others, led a $49m financing round for Histogenics Corporation.
Read more news concerning Altima Partners LLP
A sampling of Altima Partners LLP portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?